Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of IMP 08P2002F0 in Healthy Volunteers
NCT07075224Phase 2Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Nov 2025
- Primary completion
- Nov 2025
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of folinic acid + 5-fluorouracil + oxaliplatin + irinotecan in Mydriasis, sponsored by Unither Pharmaceuticals. Started Nov 2025; status: completed.
02
Drugs
folinic acid + 5-fluorouracil + oxaliplatin + irinotecan
03
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT07075224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07075224.